Trending Topic

3 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

It is with great pleasure that we present the latest edition of touchREVIEWS in Oncology & Haematology. This issue highlights the remarkable progress and innovation shaping the fields of oncology and haematology, featuring articles that delve into both emerging therapies and the evolving understanding of complex malignancies. We open with an editorial by Mohammad Ammad […]

Exercise Recommendations for Cancer-Related Fatigue, Cognitive Impairment, Sleep Problems, Depression, Pain, Anxiety, and Physical Dysfunction—A Review

Karen M Mustian, Lisa K Sprod, Michelle Janelsins, Luke J Peppone, Supriya G Mohile
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF
Published Online: Jun 25th 2012 Oncology & Hematology Review (US), 2012;8(2):81-8 DOI: https://doi.org/10.17925/OHR.2012.08.2.81
Select a Section…
1

Abstract

Overview

Cancer and its treatments produce a myriad of burdensome side effects and significantly impair quality of life (QoL). Exercise reduces side effects and improves QoL for cancer patients during treatment and recovery. Exercise prior to, during, and after completion of cancer treatments provides numerous beneficial outcomes. It represents an effective therapeutic intervention for preparing patients to successfully complete treatments, for reducing acute, chronic, and late side effects, and for improving QoL during and after treatments. This overview of exercise oncology and side effect management summarizes existing evidence-based exercise guidelines for cancer patients and survivors.

Keywords

Exercise, physical activity, cancer, side effects, quality of life, yoga, tai chi, aerobic exercise, resistance exercise, cancer-related fatigue, bone loss, muscle loss, mental health, cardiotoxicity

2

Article

Over 1.6 million Americans will be diagnosed with cancer in 2012, adding to the approximately 12 million Americans already living with a diagnosis of cancer.1 The vast majority of these cancer patients are receiving or have completed treatment for their disease. The overall survival rate for all types of cancer has increased from less than 50 % in 1975 to over 68 % in 2012.1 Therefore, many Americans with a wide variety of cancers are living beyond the historical 5-year survival marker. The number of cancer survivors will continue to increase with continued improvements in screening and treatment. Despite these improvements, however, many cancer survivors suffer from the acute, chronic, and late side effects of treatment. Acute side effects are thosewhich develop during treatment and last a short time (days, weeks, or months); chronic side effects develop during treatment and persist for months to years, and late side effects arise months or even years after treatments are complete. All of these side effects negatively impact cancer patients and survivors during, immediately following, and long after treatments. Exercise is an effective therapeutic intervention for preparing patients to successfully complete treatments, managing acute, chronic, and late side effects and improving quality of life (QOL).

Side Effects Of Cancer Treatment
Treatments for cancer often include surgery, chemotherapy, radiation therapy, hormone therapy and/or a combination of these modalities. These treatments lead to a myriad of physical and psychological side effects which subsequently interfere with a cancer patient’s ability to complete treatments as prescribed, function independently, perform activities of daily living, and live with a high QOL. Side effects are especially burdensome in older adults who are at greatest risk for functional impairment after cancer treatment. Among the most onerous side effects stemming from cancer and its treatments are cancer-related fatigue (CRF), cognitive impairment, sleep problems, depression, pain, anxiety, and physical dysfunction including impaired muscular function, reduced cardiopulmonary function, and decreased bone mineral density.

To view the full article in PDF or eBook formats, please click on the icons above.

2

References

  1. Cancer Facts & Figures, Atlanta, American Cancer Society,
    2012. Available at: www.cancer.org/Research/CancerFacts
    Figures/ACSPC-031941 (accessed September 3, 2012).

  2. Mock V, Atkinson A, Barsevick A, et al., NCCN Practice
    Guidelines for Cancer-Related Fatigue, Oncology,
    2000;14:151–61.

  3. Ryan JL, Carroll JK, Ryan EP, et al., Mechanisms of
    cancer-related fatigue, The oncologist, 2007;1:22–34.

  4. Hofman M, Ryan JL, Figueroa-Moseley CD, et al., Cancer-related
    fatigue: the scale of the problem, The oncologist, 2007;1:4–10.

  5. Morrow GR, Cancer-related fatigue: causes, consequences,
    and management, The oncologist, 2007:1–3.

  6. Mustian KM, Griggs JJ, Morrow GR, et al., Exercise and side
    effects among 749 patients during and after treatment for
    cancer: a University of Rochester Cancer Center Community
    Clinical Oncology Program Study, Supportive care in cancer :
    official journal of the Multinational Association of Supportive Care in
    Cancer, 2006;14:732–41.

  7. Mustian KM, Morrow GR, Carroll JK, et al., Integrative
    nonpharmacologic behavioral interventions for the
    management of cancer-related fatigue,
    The oncologist, 2007;1:52–67.

  8. Langeveld N, Ubbink M, Smets E, ‘I don’t have any energy’:
    The experience of fatigue in young adult survivors of
    childhood cancer, European journal of oncology nursing : the official
    journal of European Oncology Nursing Society, 2000;4:20–8.

  9. Wolfe J, Grier HE, Klar N, et al., Symptoms and suffering at
    the end of life in children with cancer, The New England journal
    of medicine, 2000;342:326–33.

  10. Cella D, Davis K, Breitbart W, et al., Cancer-related fatigue:
    prevalence of proposed diagnostic criteria in a United States
    sample of cancer survivors, Journal of clinical oncology,
    2001;19:3385–91.

  11. Forlenza MJ, Hall P, Lichtenstein P, et al., Epidemiology of
    cancer-related fatigue in the Swedish twin registry, Cancer,
    2005;104:2022–31.

  12. Teunissen SC, Wesker W, Kruitwagen C, et al., Symptom
    prevalence in patients with incurable cancer: a systematic
    review, Journal of pain and symptom management, 2007;34:94–104.

  13. Theunissen JM, Hoogerbrugge PM, van Achterberg T, et al.,
    Symptoms in the palliative phase of children with cancer,
    Pediatric blood & cancer, 2007;49:160–5.

  14. Butt Z, Rosenbloom SK, Abernethy AP, et al., Fatigue is the
    most important symptom for advanced cancer patients who
    have had chemotherapy, JNCCN, 2008;6:448–55.

  15. Minton O, Stone P, How common is fatigue in disease-free
    breast cancer survivors? A systematic review of the
    literature, Breast cancer research and treatment, 2008;112:5–13.

  16. Hockenberry-Eaton M, Hinds PS, Alcoser P, et al., Fatigue in
    children and adolescents with cancer, Journal of pediatric
    oncology nursing, 1998;15:172–82.

  17. Hinds PS, Hockenberry-Eaton M, Gilger E, et al., Comparing
    patient, parent, and staff descriptions of fatigue in pediatric
    oncology patients, Cancer nursing, 1999;22:277–88.

  18. Davies B, Whitsett SF, Bruce A, et al., A typology of fatigue in
    children with cancer, Journal of pediatric oncology nursing,
    12001;19:12–21.

  19. Gibson F, Garnett M, Richardson A, et al., Heavy to carry: a
    survey of parents’ and healthcare professionals’ perceptions
    of cancer-related fatigue in children and young people,
    Cancer nursing, 2005;28:27–35.

  20. Perdikaris P, Merkouris A, Patiraki E, et al., Changes in
    children’s fatigue during the course of treatment for
    paediatric cancer, International nursing review, 2008;55:412–9.

  21. Whitsett SF, Gudmundsdottir M, Davies B, et al.,
    Chemotherapy-related fatigue in childhood cancer:
    correlates, consequences, and coping strategies, Journal of
    pediatric oncology nursing, 2008;25:86–96.

  22. Mustian KM, Peppone LJ, Palesh OG, et al., Exercise and
    Cancer-related Fatigue, US oncology, 2009;5:20–3.

  23. Vogelzang NJ, Breitbart W, Cella D, et al., Patient, caregiver,
    and oncologist perceptions of cancer-related fatigue: results
    of a tripart assessment survey, The Fatigue Coalition, Seminars in
    hematology, 1997;34:4–12.

  24. Cornelison M, Jabbour EJ, Welch MA, Managing side effects
    of tyrosine kinase inhibitor therapy to optimize adherence in
    patients with chronic myeloid leukemia: the role of the
    midlevel practitioner, The journal of supportive oncology,
    2012;10:14–24.

  25. Janelsins M, Roscoe JA, Jean-Pierre P, Morrow GR, Cognitive
    Functioning in Breast Cancer Patients During and Following
    Chemotherapy, Supplement to American Society of Clinical Oncology,
    2009;47:[Abstract].

  26. Brezden CB, Phillips KA, Abdolell M, et al., Cognitive function
    in breast cancer patients receiving adjuvant chemotherapy,
    J Clin Oncol, 2000;18:2695–701.

  27. Ahles TA, Saykin AJ, Furstenberg CT, et al., Neuropsychologic
    impact of standard-dose systemic chemotherapy in long-term
    survivors of breast cancer and lymphoma, J Clin Oncol,
    2002;20:485–93.

  28. van Dam FS, Schagen SB, Muller MJ, et al., Impairment of
    cognitive function in women receiving adjuvant treatment for
    high-risk breast cancer: high-dose versus standard-dose
    chemotherapy, J Natl Cancer Inst, 1998;90:210–8.

  29. Wefel JS, Lenzi R, Theriault RL, et al., The cognitive sequelae
    of standard-dose adjuvant chemotherapy in women with
    breast carcinoma: results of a prospective, randomized,
    longitudinal trial, Cancer, 2004;100:2292–9.

  30. Ahles TA, Saykin AJ, McDonald BC, et al., Longitudinal
    Assessment of Cognitive Changes Associated With
    Adjuvant Treatment for Breast Cancer: Impact of
    Age and Cognitive Reserve, J Clin Oncol,
    2010;28:4434–40.

  31. Jansen CE, Dodd MJ, Miaskowski CA, et al., Preliminary
    results of a longitudinal study of changes in cognitive
    function in breast cancer patients undergoing chemotherapy
    with doxorubicin and cyclophosphamide, Psychooncology,
    2008;17:1189–95.

3

Article Information

Disclosure

The authors have no conflicts of interest to declare.

Correspondence

Karen M Mustian, PhD, MPH, ACSM, FSBM, University of Rochester School of Medicine, James P Wilmot Cancer Center, Department of Radiation Oncology, PEAK Lab, 265 Crittenden Boulevard, Rochester, NY 14642, US. E: Karen_Mustian@urmc.rochester.edu

Received

2012-09-26T00:00:00

4

Further Resources

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF
Close Popup